Yes, Aetna typically covers Ozempic for indications approved by the FDA, including the treatment of Type 2 diabetes, reducing the risk of chronic kidney disease and cardiovascular deaths, and reducing the risk of major adverse cardiovascular events in adults
Waring et al., 2000
They are not intended to represent clinical evidence in humans, and Retatrutide GLP-3 has not been approved by the FDA, EMA, or any other regulatory authority for any indication
The FDA has approved both forms, but it is essential to understand that their efficacy may vary based on individual preferences and adherence to treatment protocols
V., Zamboni, P., & Mahajan, R
I'll use a papaya soap because it makes my skin lighter